Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria.

Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria.

AIMS:To evaluate the expected life expectancy in patients with diabetes in Bulgaria and to compare it to the expected life expectancy of the non-diabetic population in the country. METHODS:It is a retrospective observational population study on individuals diagnosed with diabetes, compared to the no...

Full description

Bibliographic Details
Main Authors:	Konstantin Tachkov, Konstantin Mitov, Yordanka Koleva, Zornitsa Mitkova, Maria Kamusheva, Maria Dimitrova, Valentina Petkova, Alexandra Savova, Miglena Doneva, Dimitar Tcarukciev, Vasil Valov, Galia Angelova, Manoela Manova, Guenka Petrova
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0232815

Similar Items

Improved quality of diabetes control reduces complication costs in Bulgaria
by: Konstantin Tachkov, et al.
Published: (2019-01-01)

Incretins and SGLT-2i Therapy of Type 2 Diabetes – Real Life Study of Their Therapeutic and Economic Effects
by: Zornitsa Mitkova, et al.
Published: (2019-04-01)

Analysis of Healthcare Expenditures in Bulgaria
by: Zornitsa Mitkova, et al.
Published: (2022-01-01)

Pilot Study on the Cost of Some Oncohematology Diseases in Bulgaria
by: Konstantin Tachkov, et al.
Published: (2019-03-01)

Budget cap and pay-back model to control spending on medicines: A case study of Bulgaria
by: Zornitsa Mitkova, et al.
Published: (2022-11-01)

New Epidemiological, Clinical and Economic Data for Patients With Acromegaly in Bulgaria
by: Maria Kamusheva, et al.
Published: (2020-04-01)

Cardiovascular co-morbidity in patients with COPD in Bulgaria
by: Maria Dimitrova, et al.
Published: (2020-01-01)

Micro and macro analysis on the burden of COPD hospitalizations on the Bulgarian healthcare system
by: Konstantin Tachkov, et al.
Published: (2019-01-01)

Biosimilar Insulins and Their Impact on Prices and Utilization of Insulins in Bulgaria
by: Konstantin Tachkov, et al.
Published: (2021-06-01)

How Managed Entry Agreements Influence the Patients’ Affordability to Biological Medicines—Bulgarian Example
by: Zornitsa Mitkova, et al.
Published: (2023-08-01)

Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria
by: Konstantin Tachkov, et al.
Published: (2021-01-01)

Аn affordability of statins therapy - comparative analysis between Ukraine and Bulgaria
by: Oksana Tkachova, et al.
Published: (2019-11-01)

Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria
by: Monika Russel-Szymczyk, et al.
Published: (2019-12-01)

Review of medicine utilization for Parkinson’s disease management: the Bulgarian perspective
by: Zornitsa Mitkova, et al.
Published: (2021-08-01)

An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries
by: Maria Kamusheva, et al.
Published: (2018-03-01)

Cost of arthropathic diseases therapy with biologicals disease modifying drugs (bDMARs): a 5-year cost analysis at national level
by: Konstantin Tachkov, et al.
Published: (2022-12-01)

Comparison of Cardiovascular Medicines Prices in Four European Countries
by: Zornitsa Mitkova, et al.
Published: (2020-08-01)

Predicting the outcomes and costs for a cohort of 426 patients with Chronic Obstructive Pulmonary Disease (COPD) in Bulgaria through a Markov model
by: Konstantin Tachkov, et al.
Published: (2019-07-01)

Cost-effectiveness of different types of COH protocols for in vitro fertilization at national level
by: Boriana Benbassat, et al.
Published: (2017-01-01)

A Systematic Review of Collective Evidences Investigating the Effect of Diabetes Monitoring Systems and Their Application in Health Care
by: Maria Kamusheva, et al.
Published: (2021-03-01)

Economic and pharmaco-economic analysis of acromegaly treatment: a systematic review
by: Maria Kamusheva, et al.
Published: (2019-01-01)

Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis
by: Manoela Manova, et al.
Published: (2018-09-01)

Evaluation of the economic and social burden of chronic obstructive pulmonary disease (COPD)
by: Konstantin Tachkov, et al.
Published: (2017-07-01)

Analysis of the Household and Health Care System Expenditures in Bulgaria
by: Zornitsa Mitkova, et al.
Published: (2021-07-01)

Medication Adherence among Patients with Diabetes Mellitus and Its Related Factors—A Real-World Pilot Study in Bulgaria
by: Rayana Dinkova, et al.
Published: (2023-06-01)

Study of Symptom Severity and Adherence to Therapy of Myelofibrosis Patients Treated with Ruxolitinib
by: Vera Stoeva, et al.
Published: (2023-07-01)

Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study
by: Miglena Doneva, et al.
Published: (2022-12-01)

Generic policy in Bulgaria: a policy of failure or success?
by: Assena Stoimenova, et al.
Published: (2016-09-01)

Quality of Life and Cost Study of Rheumatoid Arthritis Therapy With Biological Medicines
by: Vladimira V. Boyadzieva, et al.
Published: (2018-07-01)

Therapeutic Results and Survival of Patients with Myelofibrosis Treated with Ruxolitinib—A Real-Life Longitudinal Study
by: Vera Stoeva, et al.
Published: (2023-10-01)

Is There a Symmetry in Disease Control and Quality of Life of Patients with Rheumatoid Arthritis Treated with Biological Therapy?
by: Konstantin Tachkov, et al.
Published: (2021-03-01)

Evaluation of potentially inappropriate medication in older patients with cardiovascular diseases—STOPP/START-based study
by: Tzvetan Krustev, et al.
Published: (2022-12-01)

Availability and reimbursement of biological products for severe asthma in Bulgaria
by: Petya Milushewa, et al.
Published: (2020-08-01)

Evaluation of the quality of life after implantation of light or standard polypropylene hernia meshes
by: Miglena Doneva, et al.
Published: (2022-06-01)

Cost-effectiveness of treatment intervention in prediabetic patients in Bulgaria
by: Stanislava Yordanova, et al.
Published: (2023-09-01)

Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria
by: Maria Dimitrova, et al.
Published: (2017-08-01)

BUDGET IMPACT ANALYSIS OF INHIBITOR HAEMOPHILIA A THERAPY WITH BYPASSING AGENTS
by: Konstantin Tachkov, et al.
Published: (2019-04-01)

Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries
by: Maria Kamusheva, et al.
Published: (2018-07-01)

Treatment patterns, adherence to international guidelines, and financial mechanisms of the market access of advanced breast cancer therapy in Bulgaria
by: Stephanie Karanyotova, et al.
Published: (2023-03-01)

Evaluating potentially inappropriate medications in elderly patients in a pharmacy setting in Bulgaria: A pilot study utilizing the EU (7)-PIM List
by: Petya Milushewa, et al.
Published: (2023-10-01)